טוען...
Rituximab Therapy for Membranous Nephropathy: A Systematic Review
Background and objectives: The treatment of membranous nephropathy (MN) remains controversial. Rituximab, which selectively targets B cells, has emerged as a possible alternative treatment option with limited toxicity. Design, setting, participants, & measurements: The available data on rituxima...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Nephrology
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2666426/ https://ncbi.nlm.nih.gov/pubmed/19279120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.05231008 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|